NVIDIA enters the back half of September with the stock sliding, options traders moving to their most defensive posture of the year, and a director offloading shares at pace — three signals that reinforce each other even as the underlying short story stays quiet.
The price action is the first thing to address head-on. NVDA closed at $212.17 on Tuesday, down 6% on the week and off about 5.8% over the past month. That erases a chunk of the post-August 26 rally — the quarter in which the stock jumped 7% in a single session after earnings. Previous notes in this series flagged the risk that the grind higher could stall without a near-term catalyst, and that is precisely what is now playing out. The next earnings date is November 25, leaving ten weeks of open water. The bounce on Tuesday (+0.6%) arrested the slide marginally, but the week's damage is real.
The options market is flashing the clearest signal of concern. Defensive positioning has reached a full-year extreme: the put/call ratio hit 1.10 on Tuesday, its highest reading in 52 weeks against a 52-week low of 0.70. More striking, that reading is 2.7 standard deviations above the 20-day mean of 0.90 — a z-score that marks one of the sharpest single-session spikes in protection demand this name has seen. As recently as mid-August, the PCR was running below 0.83 on most days. The shift over the past week has been abrupt. Traders are buying puts faster than calls in a way that goes well beyond normal hedging — this is a crowd actively seeking downside protection into a tape that has no obvious floor until November.
The short interest data, by contrast, tells a far calmer story. Bears have barely moved. Short interest ticked up roughly 4% on the week to 1.20% of free float — still near the cycle lows that have held since the pre-earnings cover at the end of August. Borrow costs have actually fallen, down 9% on the week to 0.24%, and the lending pool remains one of the deepest in the large-cap universe. There is no squeeze dynamic here. The availability picture is maxed out, reflecting essentially unlimited shares to borrow. Short sellers are not the ones driving the anxiety in options — something else is.
That something else is most visible in the insider register. Director Mark Stevens sold approximately $296 million worth of NVIDIA shares across four trading days between September 2 and September 4, with no 10b5-1 plan on file. These were discretionary open-market sales, made with the stock trading between $224 and $234 — well above where it closed this week. Stevens was not the only insider active in the period; a separate director gifted 500,000 shares under a pre-arranged plan on September 2, and an EVP received a grant on September 9. But the Stevens sales stand out for their size and discretionary nature. Over the 90-day window, net insider selling across the name totals roughly $839 million. That is not a doomsday signal for a stock this large, but it is context the options positioning echoes.
The Street remains structurally bullish, and the analyst picture has not shifted materially this week. Following the August 26 print, a wave of firms raised targets — JP Morgan moved to $320 from $280, Bernstein to $400 from $315, RBC to $330 from $300, among others. Piper Sandler initiated coverage at Overweight with a $300 target on September 10. The consensus mean target is $328.66, implying roughly 55% upside from current levels on a stock that has pulled back into the $210s. Bulls point to data center demand, AI infrastructure spending, and the company's expanding ecosystem. Bears — a thin crowd in the analyst community — flag hyperscaler concentration risk and competition. Factor scores lean bullish: EPS momentum over 30 days ranks in the 93rd percentile, and the analyst recommendation differential ranks 91st. The short score at 29.7 is one of the lowest readings in the dataset, consistent with the thin short interest.
What to watch next is whether the options defensiveness proves prescient or premature — the put/call ratio at a 52-week high with short sellers sitting on their hands is an unusual divergence, and the gap between where the Street has its targets and where the stock is trading will face its next real test on November 25.
See the live data behind this article on ORTEX.
Open NVDA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
